Table 3.

Associations between polyomavirus seroreactivity and cutaneous SCC, Tampa, FL, 2007 to 2009

Controls (n = 300)SCC cases (n = 173)
Polyomavirus seroreactivityn%n%ORa95% CIa
MCV
 Seronegative8026.73319.11.00Reference
 Seropositive22073.314080.91.580.96–2.60
 Quartile 17525.03117.91.00Reference
 Quartile 27525.03922.51.440.78–2.69
 Quartile 37525.05330.61.710.94–3.11
 Quartile 47525.05028.91.530.84–2.78
   Ptrend    0.15
JCV
 Seronegative10836.04526.01.00Reference
 Seropositive19264.012874.01.400.89–2.20
 Quartile 17525.02916.81.00Reference
 Quartile 27525.04224.31.740.92–3.27
 Quartile 37525.03822.01.220.65–2.29
 Quartile 47525.06437.01.470.81–2.69
   Ptrend    0.44
  • aORs and 95% CIs adjusted for age and sex.